Literature DB >> 12937415

The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease.

Stéphane Haïk1, Baptiste A Faucheux, Véronique Sazdovitch, Nicolas Privat, Jean-Louis Kemeny, Armand Perret-Liaudet, Jean-Jacques Hauw.   

Abstract

Prion epizoonoses spread from animals consumed by humans raise the question of which pathways lead to prion neuroinvasion after oral exposure of humans. Here we show that neurons of sympathetic ganglia of patients with variant Creutzfeldt-Jakob disease (vCJD) accumulate the abnormal isoform of the protein prion. This observation shows the involvement of the sympathetic nervous system in the pathogenesis of vCJD and suggests a role for GUT-associated sympathetic neurons in prion propagation in humans after oral contamination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937415     DOI: 10.1038/nm922

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  16 in total

1.  Interaction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure.

Authors:  Gauthier Dorban; Valérie Defaweux; Caroline Demonceau; Sylvain Flandroy; Pierre-Bernard Van Lerberghe; Nandini Falisse-Poirrier; Joëlle Piret; Ernst Heinen; Nadine Antoine
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

2.  Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt-Jakob disease.

Authors:  Hélène Zéphir; Tanya Stojkovic; Jérome de Seze; Claude-Alain Maurage; Katell Peoc'h; Stéphane Haïk; Patrick Vermersch
Journal:  J Neurol       Date:  2009-02-07       Impact factor: 4.849

3.  Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Authors:  Sophie Halliez; Fabienne Reine; Laetitia Herzog; Emilie Jaumain; Stéphane Haïk; Human Rezaei; Jean-Luc Vilotte; Hubert Laude; Vincent Béringue
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.

Authors:  C Ishida; S Okino; T Kitamoto; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

5.  Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie.

Authors:  Achim Thomzig; Walter Schulz-Schaeffer; Christine Kratzel; Jessica Mai; Michael Beekes
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 6.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

7.  Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease.

Authors:  Alexander H Peden; Diane L Ritchie; Mark W Head; James W Ironside
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

8.  Biochemical properties of highly neuroinvasive prion strains.

Authors:  Cyrus Bett; Shivanjali Joshi-Barr; Melanie Lucero; Margarita Trejo; Pawel Liberski; Jeffery W Kelly; Eliezer Masliah; Christina J Sigurdson
Journal:  PLoS Pathog       Date:  2012-02-02       Impact factor: 6.823

9.  Application of Atomic Dielectric Resonance Spectroscopy for the screening of blood samples from patients with clinical variant and sporadic CJD.

Authors:  Timothy J Fagge; G Robin Barclay; G Colin Stove; Gordon Stove; Michael J Robinson; Mark W Head; James W Ironside; Marc L Turner
Journal:  J Transl Med       Date:  2007-08-30       Impact factor: 5.531

10.  Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.

Authors:  Jean Y Douet; Caroline Lacroux; Naima Aron; Mark W Head; Séverine Lugan; Cécile Tillier; Alvina Huor; Hervé Cassard; Mark Arnold; Vincent Beringue; James W Ironside; Olivier Andréoletti
Journal:  Emerg Infect Dis       Date:  2017-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.